- Home
- QNCX vs CHMI Comparison
QNCX vs CHMI Comparison
Compare QNCX & CHMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- CHMI
- Stock Information
- Founded
- QNCX 2012
- CHMI 2012
- Country
- QNCX United States
- CHMI United States
- Employees
- QNCX N/A
- CHMI N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- CHMI Real Estate Investment Trusts
- Sector
- QNCX Health Care
- CHMI Real Estate
- Exchange
- QNCX Nasdaq
- CHMI Nasdaq
- Market Cap
- QNCX 47.7M
- CHMI 96.0M
- IPO Year
- QNCX 2019
- CHMI 2013
- Fundamental
- Price
- QNCX $1.53
- CHMI $2.70
- Analyst Decision
- QNCX Strong Buy
- CHMI Hold
- Analyst Count
- QNCX 5
- CHMI 2
- Target Price
- QNCX $8.00
- CHMI N/A
- AVG Volume (30 Days)
- QNCX 336.8K
- CHMI 313.3K
- Earning Date
- QNCX 08-12-2025
- CHMI 08-07-2025
- Dividend Yield
- QNCX N/A
- CHMI 22.14%
- EPS Growth
- QNCX N/A
- CHMI N/A
- EPS
- QNCX N/A
- CHMI N/A
- Revenue
- QNCX N/A
- CHMI $27,506,000.00
- Revenue This Year
- QNCX N/A
- CHMI N/A
- Revenue Next Year
- QNCX N/A
- CHMI $54.92
- P/E Ratio
- QNCX N/A
- CHMI N/A
- Revenue Growth
- QNCX N/A
- CHMI 19.59
- 52 Week Low
- QNCX $0.51
- CHMI $2.34
- 52 Week High
- QNCX $2.45
- CHMI $3.95
- Technical
- Relative Strength Index (RSI)
- QNCX 66.23
- CHMI 29.78
- Support Level
- QNCX $1.43
- CHMI $2.93
- Resistance Level
- QNCX $1.68
- CHMI $3.03
- Average True Range (ATR)
- QNCX 0.13
- CHMI 0.07
- MACD
- QNCX 0.03
- CHMI -0.02
- Stochastic Oscillator
- QNCX 83.02
- CHMI 0.00
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About CHMI Cherry Hill Mortgage Investment Corporation
Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.